2017 Congress
OBJECTIVE
The goal of the Course is to cover the most difficult diagnostic problems encountered by practicing pathologists in the areas of cutaneous and ocular melanoma.
The approach of the Course will be practical based on the extensive experience of the Directors of the Course and other invited speakers. The Course will consist of a series of didactic lectures and interactive sessions during the two-day period.
Digitized images of specific cases will be available for review in advance of the Course and will be discussed in the interactive sessions of the Course.
Speakers
Pr Raymond Barnhill,
Institut Curie and University of Paris Descartes, Paris, France
Pr Klaus Busam,
Memorial Sloan Kettering Cancer Center, New York, USA
Pr Richard Scolyer,
Royal Prince Alfred Hospital, Melanoma Institute of Australia and the University of Sydney, Sydney, Australia
Pr Nathalie Cassoux,
Institut Curie, Paris, France
Dr Loren Clarke,
Myriad Genetic Laboratories, Salt Lake City, USA
Pr Sarah Coupland,
University of Liverpool, Liverpool, United Kingdom
Dr Arnaud de la Fouchardière,
Centre Léon Bérard, Lyon, France
Pr David Elder,
University of Pennsylvania, Philadelphia USA
Pr Georgina Long
Sydney Medical School, Sydney, Australia
Dr Sophie Piperno-Neumann,
Institut Curie, Paris, France
Dr Manuel Rodrigues,
Institut Curie, Paris, France
Pr Alan Spatz,
McGill University, Montreal Canada
Pr Jonathan Stretch,
Sydney Medical School, Sydney, Australia
Dr Thomas Wiesner,
University of Vienna, Vienna, Austria
Pr Artur Zembowicz,
Tufts Medical School, Boston, USA
Non exhaustive list of topics
- General approach to the difficult melanocytic lesion
- Dysplastic and other atypical cutaneous melanocytic nevi
- Spitzoid melanocytic tumors
- Blue nevi and atypical variants
- Nevoid, desmoplastic, blue nevus-like, conventional cutaneous, pediatric, acral, mucosal, conjunctival, uveal melanomas
- Primary acquired melanosis
- Melanocytic lesions of the nail apparatus
- The latest AJCC guidelines (8th Edition) for cutaneous and ocular melanoma staging
- Practical immunohistochemistry and molecular analysis of melanocytic lesions
- Immune checkpoint pathways
- The reporting of melanoma and prognostic factors
- What the clinician expects from the pathologist
